Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Beckman, M. Creager, P. Libby (2002)
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.JAMA, 287 19
Zebrack Zebrack, Muhlestein Muhlestein, Horne Horne, Anderson Anderson (2002)
The Intermountain Heart Collaboration Study Group. C‐reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with anginaJ Am Coll Cardiol, 39
A. Simon, J. Gariépy, G. Chironi, J. Mégnien, J. Levenson (2002)
Intima–media thickness: a new tool for diagnosis and treatment of cardiovascular riskJournal of Hypertension, 20
G. Geroulakos, G. Ramaswami, Martin Veller, G. Fisher, S. Renton, A. Nicolaides, H. Waldron, J. Diamond, R. Elkeles (1994)
Arterial Wall Changes in Type 2 Diabetic SubjectsDiabetic Medicine, 11
S. Bannan, M. Mansfield, Peter Grant (1998)
Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patientsDiabetologia, 41
EvaHurt-Camejo, UrbanOlsson, OlovWiklund, GöranBondjers, GermánCamejo (1997)
Cellular Consequences of the Association of ApoB Lipoproteins With ProteoglycansArteriosclerosis, Thrombosis, and Vascular Biology
G. Biondi‐Zoccai, A. Abbate, G. Liuzzo, L. Biasucci (2003)
Atherothrombosis, inflammation, and diabetes.Journal of the American College of Cardiology, 41 7
P. Ridker (2003)
Clinical application of C-reactive protein for cardiovascular disease detection and prevention.Circulation, 107 3
G. Blake, P. Ridker (2002)
C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.Arteriosclerosis, thrombosis, and vascular biology, 22 10
(1999)
Report of a WHO Consultation, Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organisation
R. Grimble (2002)
Inflammatory status and insulin resistanceCurrent Opinion in Clinical Nutrition and Metabolic Care, 5
E. Leinonen, J. Salonen, R. Salonen, R. Koistinen, P. Leinonen, Seppo Sarna, M. Taskinen (2002)
Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.Diabetes care, 25 10
T. Temelkova-Kurktschiev, C. Koehler, W. Leonhardt, F. Schaper, E. Henkel, Gabriele Siegert, Markolf Hanefeld (1999)
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.Diabetes care, 22 2
Uk-Prospective-Diabetes-Study-Group (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 352
(2001)
Phospholipase A2 in vascular disease
C. Stehouwer, M. Gall, J. Twisk, E. Knudsen, J. Emeis, H. Parving (2002)
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.Diabetes, 51 4
I. Stratton, A. Adler, A. Neil, D. Matthews, S. Manley, C. Cull, D. Hadden, R. Turner, R. Holman (2000)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyBMJ : British Medical Journal, 321
C. Stehouwer, Giel Yudkin, Jacqueline Nijpels, Robert Dekker, Lex Heine, Bouter Agnes, Victor Jager, Piet Hinsbergh, Jef Kostense, John Emeis, Stehouwer, Arterioscler Thromb, Vasc Biol (1999)
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.Arteriosclerosis, thrombosis, and vascular biology, 19 12
D. Steinberg (2002)
Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crimeNature Medicine, 8
G. Engström, L. Stavenow, B. Hedblad, P. Lind, K. Eriksson, L. Janzon, F. Lindgärde (2003)
Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.Diabetes, 52 2
P. Ridker, C. Hennekens, Julie Buring, N. Rifai (2000)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.The New England journal of medicine, 342 12
Y. Yamasaki, H. Nishizawa, Ya Sakamoto, M. Matsuhisa (2000)
Carotid Intima-Media Thickness in Japanese Type 2 Diabetic Subjects
Diabetes Investigators (2001)
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised studyThe Lancet, 357
Mark Adams, A. Nakagomi, Anthony Keech, J. Robinson, R. McCredie, Bailey Bp, Saul Freedman, David Celermajer (1995)
Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease.Circulation, 92 8
E. Leinonen, E. Hurt-Camejo, O. Wiklund, L. Hultén, A. Hiukka, M. Taskinen (2003)
Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.Atherosclerosis, 166 2
M. Taskinen, Timo Kussi, E. Helve, Esko Nikkia, H. Yki-Jarvinen (1988)
Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent DiabetesArteriosclerosis, Thrombosis, and Vascular Biology, 8
D. Power (2006)
Standards of medical care in diabetes.Diabetes care, 29 2
Y. Yamasaki, M. Kodama, H. Nishizawa, K. Sakamoto, M. Matsuhisa, Y. Kajimoto, K. Kosugi, Y. Shimizu, R. Kawamori, M. Hori (2000)
Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease.Diabetes care, 23 9
M. Laakso, S. Lehto (1997)
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance.Atherosclerosis, 137 Suppl
J. Zebrack, J. Muhlestein, B. Horne, Jeffrey Anderson (2002)
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.Journal of the American College of Cardiology, 39 4
S. Steffens, F. Mach (2004)
Inflammation and AtherosclerosisHerz, 29
D. Streja, P. Cressey, S. Rabkin (2003)
Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.Journal of diabetes and its complications, 17 3
A. Tedgui, Z. Mallat (2001)
Anti-Inflammatory Mechanisms in the Vascular WallCirculation Research: Journal of the American Heart Association, 88
S. Lim, A. Caballero, P. Smakowski, F. Logerfo, E. Horton, A. Veves (1999)
Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.Diabetes care, 22 11
J. Pickup, M. Crook (1998)
Is Type II diabetes mellitus a disease of the innate immune system?Diabetologia, 41
P. Barter (2002)
Effects of inflammation on high-density lipoproteins.Arteriosclerosis, thrombosis, and vascular biology, 22 7
J. Vakkilainen, M. Jauhiainen, K. Ylitalo, I. Nuotio, J. Viikari, C. Ehnholm, M. Taskinen (2002)
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.Journal of lipid research, 43 4
D. Goff, R. D'Agostino, S. Haffner, M. Saad, L. Wagenknecht (2000)
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.Diabetes care, 23 7
R. Turner, C. Fox, Matthews, H. Mcelroy, C. Cull, R. Holman, P. Neil, D. Hadden, D. Wright, É. Manley, I. Stratton, Uk Diabetes, E. Kohner, Frighi, Michael Gnant (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.The Lancet
A. Folsom, N. Aleksic, D. Catellier, H. Juneja, Kenneth Wu (2002)
C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.American heart journal, 144 2
S. Haffner, Ralph DAgostino, Mohammed Saad, D. O'Leary, Peter Savage, Marian Rewers, J. Selby, Richard Bergman, L. Mykkänen (2000)
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).The American journal of cardiology, 85 12
E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, G. Camejo (1997)
Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis.Arteriosclerosis, thrombosis, and vascular biology, 17 6
J. Radziuk (2000)
Insulin sensitivity and its measurement: structural commonalities among the methods.The Journal of clinical endocrinology and metabolism, 85 12
A. Jager, V. Hinsbergh, P. Kostense, J. Emeis, G. Nijpels, J. Dekker, R. Heine, L. Bouter, C. Stehouwer (2000)
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.Diabetes, 49 3
Abstract. Objectives. The objective of this study was to assess the relationship between inflammation, endothelial activation and incipient atherosclerosis in type 2 diabetes. Design. Cross‐sectional study. Setting and subjects. We studied 239 type 2 diabetic patients (71 with clinical cardiovascular disease (CVD)) and 78 healthy control subjects, aged 50–75 in a single research centre. Methods. Carotid intima‐media thickness (IMT) was determined by ultrasound. Circulating intracellular adhesion molecule‐1, vascular cell adhesion molecule‐1, E‐selectin, ultra‐sensitive C‐reactive protein, human serum amyloid A, interleukin‐6, monocyte colony‐stimulating factor, secretory nonpancreatic phospholipase A2 type IIA, glucose, HbA1c, and lipid/lipoprotein variables were measured. Results. Carotid IMT was significantly thicker in diabetic patients than healthy controls across the whole age range. IMT was also thicker in diabetic patients with, than without, CVD, but this difference disappeared after controlling for confounding factors. Concentrations of the inflammatory and endothelial markers except IL‐6 were significantly higher in the diabetic patients than in healthy controls, but comparable in diabetic patients with and without CVD. The main determinants of IMT in the diabetic patients were blood pressure, age and diabetes duration. Conclusions. Low‐grade inflammation and endothelial activation are increased in diabetic patients but do not associate with IMT or clinical CVD. The inflammatory reaction seems to be rather a feature of the metabolic syndrome than a direct determinant of atherosclerosis.
Journal of Internal Medicine – Wiley
Published: Aug 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.